Prothena Plc Stock Target Price and Analyst Consensus
| PRTA Stock | USD 6.29 0.03 0.48% |
The current analyst and expert consensus on Prothena Plc is Strong Buy, with 5 strong buy opinions. The current projected Prothena Plc target price consensus is 49.00 with 10 analyst opinions. Check out Macroaxis Advice on Prothena Plc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.The most common way Prothena plc analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Prothena Plc executives and customers to further validate their buy or sell advice. Prothena Plc buy-or-sell recommendation module provides average expert sentiment on the projected Prothena plc target price to derive its highest and lowest estimates based on projected price volatility of 5.2507.
Lowest Forecast 44.59 | Highest Forecast 54.39 | Target Price 49 |
It's important to approach Prothena Plc's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Prothena Plc Target Price Consensus
Prothena target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Prothena Plc's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 10 | Strong Buy |
Most Prothena analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Prothena stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Prothena plc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationProthena Plc Target Price Projection
Prothena Plc's current and average target prices are 6.29 and 49.00, respectively. The current price of Prothena Plc is the price at which Prothena plc is currently trading. On the other hand, Prothena Plc's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On Prothena Plc Target Price
Prothena Plc Analyst Ratings
Prothena Plc's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Prothena Plc stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Prothena Plc's financials, market performance, and future outlook by experienced professionals. Prothena Plc's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Prothena Plc price targets
Prothena Plc's stock target price is an estimate of its future price, usually made by analysts. Using Prothena Plc's target price to determine if it is a suitable investment can be done through the following steps:- Look at Prothena Plc's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Prothena Plc's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Prothena Plc Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Prothena Plc is a key component of Prothena Plc valuation and have some predictive power on the future returns of a Prothena Plc.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Prothena Plc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Momentum Invested over 30 shares | |
 | Adviser Favorites Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Social Domain Invested few shares | |
 | Banking Invested over 40 shares | |
 | ESG Investing Invested few shares | |
Check out Macroaxis Advice on Prothena Plc to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Please note, the presentation of Prothena Plc's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prothena Plc's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prothena Plc's management manipulating its earnings.